Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
If you read Part 1 of this series, you’ve already seen how Interactive Review Listings (IRLs) simplify and speed up the core data review process.
How AI evolved from pattern recognition to autonomous reasoning, and why pharmaceutical leaders need to understand the difference The $2.23 Billion Question Developing a single
Let’s take a minute to think about what it really takes to bring a new medicine to patients- it’s a massive, critical effort, but too
AI’s potential in life sciences isn’t limited by technology- it’s limited by how we communicate with it. The most powerful AI tools can fall short
Clinical trials are under tremendous pressure. Over the past decade, protocols have become more complex, regulatory requirements have tightened, and the cost of bringing a
Traditional data quality checks have served clinical research well for decades, catching obvious issues like missing fields and chronological errors. But as studies grow more
Clinical data teams know this challenge all too well- creating SDTM (Study Data Tabulation Model) specifications and programming deliverables can take upwards of 8 hours
Clinical trials are experiencing a major transformation. While the core goal remains bringing safe, effective treatments to patients, how we reach that goal is changing
In our previous blog, we took an in-depth look at AI hallucinations, including what they are, why they matter, and how they can be measured.
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.
